A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx)

Volume 11, Issue 1, December 2022 .

Source: OncoImmunology - October 5, 2022 Category: Cancer & Oncology Authors: Linlin Guo Jay Overholser Heather Darby Nicholas J. Ede Pravin T.P Kaumaya Source Type: research